2nd Jul 2015 08:30
LONDON (Alliance News) - Ergomed PLC on Thursday said it has appointed Andrew Mackie as chief business officer and as an executive director on its board.
The pharmaceutical services company said Mackie has held senior roles with pharmaceutical companies including Sanofi, Novartis and Eli Lilly, and he joins from his role in the business development team at the latter.
Ergomed shares were untraded Thursday, having last traded at 180.00 pence.
By Sam Unsted; [email protected]; @SamUAtAlliance
Copyright 2015 Alliance News Limited. All Rights Reserved.
Related Shares:
ERGO.L